Synovial fibroblasts from patients with osteoarthritis in culture produced parathyroid hormone-related peptide (PTHrP) on treatment with phorbol ester (TPA) in a doseand time-dependent manner. The levels of PTHrP immunoreactivity in the conditioned medium of synovial fibroblast cultures were measured using specific PTHrP antibody. The maximum production was obtained at a concentration of 10 -8 M and 24 h after TPA treatment. But sensitivity to TPA of synovial fibroblasts differed among four patients from slight to marked. PTHrP production was also induced with inflammatory cytokines, such as 1 nglml of IL-lcx, IL-113, IL-6 and TNF-~ and 10 -6 M prostaglandin E2, after 24 h treatment. The expression of PTHrP was confirmed by reverse-transeriptase polymerase chain reaction. Since the synovial fibroblasts isolated from osteoarthritic patients produce high levels of IL-6 and IL-8, typical cytokines produced in synovial fibroblasts, production of PTHrP may provide new insight into the pathophysiology of joint disorder.© 1998 Federation of European Biochemical Societies.Key words: Parathyroid hormone-related peptide; Osteoarthritis; Synovial fibroblast; Cytokine; Phorbol ester; Human endothelial cells in blood vessels, were demonstrated to express PTHrP by immunohistochemistry [9]. However, it has not yet been determined whether PTHrP is actually produced in synovial cells established from synovial membrane in culture. Synovial fibroblasts, abundant components of the synovial membrane, proliferate markedly in arthritis and cause hypertrophy. Then, synovial fibroblasts isolated from synovial membrane of osteoarthritis were established in culture, and examined for PTHrP production in the presence or absence of activating factors such as phorbol ester, inflammatory cytokines and prostaglandin E2 (PGE2). In this study we demonstrate that production of PTHrP was induced in synovial fibroblasts with not only phorbol ester TPA, but also inflammatory cytokines and PGE2. PTHrP influences the proliferation of lymphocytes [10], and the N-terminal peptide portion (1-34) acts as a stimulator of in vivo bone resorption when applied intermittently to neonatal mice [11]. Our findings suggested that PTHrP produced by synovial fibroblasts plays a novel role as a paracrine/autocrine factor in the pathophysiology of osteoarthritis.
Materials and methods